- Home
- CAAP vs BHVN Comparison
CAAP vs BHVN Comparison
Compare CAAP & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAAP
- BHVN
- Stock Information
- Founded
- CAAP 1998
- BHVN 2013
- Country
- CAAP Luxembourg
- BHVN United States
- Employees
- CAAP N/A
- BHVN N/A
- Industry
- CAAP Aerospace
- BHVN Biotechnology: Pharmaceutical Preparations
- Sector
- CAAP Consumer Discretionary
- BHVN Health Care
- Exchange
- CAAP Nasdaq
- BHVN Nasdaq
- Market Cap
- CAAP 3.3B
- BHVN 1.9B
- IPO Year
- CAAP 2018
- BHVN 2017
- Fundamental
- Price
- CAAP $20.89
- BHVN $14.62
- Analyst Decision
- CAAP Strong Buy
- BHVN Strong Buy
- Analyst Count
- CAAP 2
- BHVN 14
- Target Price
- CAAP $24.35
- BHVN $58.85
- AVG Volume (30 Days)
- CAAP 109.7K
- BHVN 2.0M
- Earning Date
- CAAP 08-20-2025
- BHVN 08-07-2025
- Dividend Yield
- CAAP N/A
- BHVN N/A
- EPS Growth
- CAAP N/A
- BHVN N/A
- EPS
- CAAP 1.05
- BHVN N/A
- Revenue
- CAAP $1,858,038,000.00
- BHVN N/A
- Revenue This Year
- CAAP N/A
- BHVN $3.00
- Revenue Next Year
- CAAP $12.97
- BHVN $59.97
- P/E Ratio
- CAAP $19.46
- BHVN N/A
- Revenue Growth
- CAAP 28.46
- BHVN N/A
- 52 Week Low
- CAAP $13.97
- BHVN $13.87
- 52 Week High
- CAAP $22.13
- BHVN $55.70
- Technical
- Relative Strength Index (RSI)
- CAAP 62.62
- BHVN 42.86
- Support Level
- CAAP $19.82
- BHVN $14.00
- Resistance Level
- CAAP $20.28
- BHVN $15.09
- Average True Range (ATR)
- CAAP 0.51
- BHVN 0.72
- MACD
- CAAP 0.10
- BHVN 0.14
- Stochastic Oscillator
- CAAP 97.87
- BHVN 47.71
About CAAP Corporacion America Airports SA
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.
About BHVN Biohaven Ltd.
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.